Abbott agrees to pay nearly $385 million to US government over alleged infant formula false claims
Abbott has agreed to pay nearly $385 million to resolve alleged false claims involving infant formula made at its Michigan facility. The settlement follows the company’s 2022 recall and plant closure amid contamination concerns. Abbott maintains that no distributed infant formula tested positive for Cronobacter and says government testing found…
The Times of India ·